D B THOMAS|F H WALTER - JoVE Visualize

Showing results (201-210 of 225) with videos related to

Pageof 23

Sort By:

Journal of Oncology|January 14, 2020

Screening of Pleural Mesothelioma Cell Lines for Kinase Activity May Identify New Mechanisms of Therapy Resistance in Patients Receiving Platin-Based ChemotherapySabrina Borchert, Pia-Maria Suckrau, Michael Wessolly, et al.

Translational Lung Cancer Research|August 25, 2021

Mitogen signal-associated pathways, energy metabolism regulation, and mediation of tumor immunogenicity play essential roles in the cellular response of malignant pleural mesotheliomas to platinum-based treatment: a retrospective studyAlexander Mathilakathu, Sabrina Borchert, Michael Wessolly, et al.

American Journal of Epidemiology|August 15, 1991

Occupational exposure to electromagnetic fields and breast cancer in menP A Demers, D B Thomas, K A Rosenblatt, et al.

Journal of the National Cancer Institute|June 19, 1991

Breast cancer in men: aspects of familial aggregationK A Rosenblatt, D B Thomas, A McTiernan, et al.

Cancer Causes & Control : CCC|March 1, 1993

Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States menH Stalsberg, D B Thomas, K A Rosenblatt, et al.

British Journal of Cancer|June 13, 2014

Possible pro-carcinogenic association of endotoxin on lung cancer among Shanghai women textile workersH Checkoway, J I Lundin, S Costello, et al.

Scientific Reports|October 30, 2020

Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesotheliomaSabrina Borchert, Pia-Maria Suckrau, Robert F H Walter, et al.

National Cancer Institute Monograph|December 1, 1985

Rationale and design of cancer chemoprevention studies in SeattleR L Prentice, G S Omenn, G E Goodman, et al.

Cancers|April 30, 2021

Digital Gene Expression Analysis of Epithelioid and Sarcomatoid Mesothelioma Reveals Differences in ImmunogenicityLuka Brcic, Alexander Mathilakathu, Robert F H Walter, et al.

Cancer Management and Research|September 14, 2020

A Novel Epitope Quality-Based Immune Escape Mechanism Reveals Patient's Suitability for Immune Checkpoint InhibitionMichael Wessolly, Susann Stephan-Falkenau, Anna Streubel, et al.

Pageof 23

Showing results (201-210 of 225) with videos related to

Sort By:

Pageof 23

Journal of Oncology|January 14, 2020

Screening of Pleural Mesothelioma Cell Lines for Kinase Activity May Identify New Mechanisms of Therapy Resistance in Patients Receiving Platin-Based ChemotherapySabrina Borchert, Pia-Maria Suckrau, Michael Wessolly, et al.

Translational Lung Cancer Research|August 25, 2021

Mitogen signal-associated pathways, energy metabolism regulation, and mediation of tumor immunogenicity play essential roles in the cellular response of malignant pleural mesotheliomas to platinum-based treatment: a retrospective studyAlexander Mathilakathu, Sabrina Borchert, Michael Wessolly, et al.

American Journal of Epidemiology|August 15, 1991

Occupational exposure to electromagnetic fields and breast cancer in menP A Demers, D B Thomas, K A Rosenblatt, et al.

Journal of the National Cancer Institute|June 19, 1991

Breast cancer in men: aspects of familial aggregationK A Rosenblatt, D B Thomas, A McTiernan, et al.

Cancer Causes & Control : CCC|March 1, 1993

Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States menH Stalsberg, D B Thomas, K A Rosenblatt, et al.

British Journal of Cancer|June 13, 2014

Possible pro-carcinogenic association of endotoxin on lung cancer among Shanghai women textile workersH Checkoway, J I Lundin, S Costello, et al.

Scientific Reports|October 30, 2020

Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesotheliomaSabrina Borchert, Pia-Maria Suckrau, Robert F H Walter, et al.

National Cancer Institute Monograph|December 1, 1985

Rationale and design of cancer chemoprevention studies in SeattleR L Prentice, G S Omenn, G E Goodman, et al.

Cancers|April 30, 2021

Digital Gene Expression Analysis of Epithelioid and Sarcomatoid Mesothelioma Reveals Differences in ImmunogenicityLuka Brcic, Alexander Mathilakathu, Robert F H Walter, et al.

Cancer Management and Research|September 14, 2020

A Novel Epitope Quality-Based Immune Escape Mechanism Reveals Patient's Suitability for Immune Checkpoint InhibitionMichael Wessolly, Susann Stephan-Falkenau, Anna Streubel, et al.

Pageof 23